<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url><loc>https://oncdata.com/article/d72b6589-85b0-46f3-8cb8-beb305ac0ddf</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T12:49:38.857Z</news:publication_date><news:title>Aromatase Inhibitors vs Tamoxifen and Incident Intracranial Meningioma Risk in Breast Cancer</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/7593c94d-e2ba-40f4-93b6-7581dbf7f94d</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T12:49:38.636Z</news:publication_date><news:title>Accelerated Partial-Breast Versus Whole-Breast Irradiation in Low-Risk Invasive Breast Cancer</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/d9633f8a-ace9-4e1c-931c-4b3bbcb09396</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T02:49:34.851Z</news:publication_date><news:title>Adjuvant ICI and Chemotherapy Linked to Longer DFS in High-Risk UTUC</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/b9d807cf-68bf-4c65-8967-7727387f93e1</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T02:49:34.693Z</news:publication_date><news:title>Preoperative Staging Completion Rates in Medicare Rectal Cancer Proctectomy</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/87b116d5-c0c0-4cd5-bb1c-063c47729370</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T22:49:40.314Z</news:publication_date><news:title>Complex Karyotype and Non-BTK Mutations Linked to BTK Inhibitor Resistance in CLL</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/0ad02815-bbac-4add-b7d1-b6ab8949a8c3</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T22:49:40.214Z</news:publication_date><news:title>Updated CAP-ASCP Guideline on HER2 Testing in Advanced Gastroesophageal Adenocarcinoma</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/cda876f5-f571-4c3f-8cd4-ed98e7fb1efe</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T12:49:50.338Z</news:publication_date><news:title>Etentamig (Investigational) in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/819052c8-2722-4013-a68e-3ca2d9366239</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T12:49:50.221Z</news:publication_date><news:title>Carfilzomib-Based Induction, ASCT, and Maintenance in Multiple Myeloma</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/abaaad6b-0ce6-4a6e-aead-20a91526849a</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T02:49:44.230Z</news:publication_date><news:title>First-Line EGFR-TKIs With Chemotherapy Improve Survival in EGFR-Mutated NSCLC</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/e9613465-6ffd-4250-9f28-b182a450421c</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T22:49:11.796Z</news:publication_date><news:title>CAR T-Cell Therapy Linked to Higher Severe Neurotoxicity in Octogenarians</news:title></news:news></url>
  <url><loc>https://oncdata.com/article/ac8104d1-7a29-4545-8cf5-fee9a909803d</loc><news:news><news:publication><news:name>Oncology Data Advisor</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T22:49:11.697Z</news:publication_date><news:title>Hypofractionated vs Conventional Breast Radiotherapy and Lymphocyte Recovery</news:title></news:news></url>
</urlset>